{
    "nctId": "NCT02752009",
    "briefTitle": "Evaluation Of Lymph Nodes After Neoadjuvant Chemotherapy",
    "officialTitle": "Evaluation Of Axillary Lymph Node Metastases With Sentinel Lymph Node Biopsy After Neoadjuvant Therapy In Breast Cancer Patients",
    "overallStatus": "WITHDRAWN",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 0,
    "primaryOutcomeMeasure": "False Negative Rate (FNR) Of Sentinel Lymph Node Biopsy At The Time Of Surgery",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Eligible patients will include any patients with biopsy-proven breast cancer and biopsy-proven axillary lymph node metastases at Beth Israel Deaconess Medical Center who are candidates for Neoadjuvant Chemotherapy or Neoadjuvant Endocrine therapy.\n* A core needle biopsy or fine needle aspiration is acceptable for diagnosis of metastatic disease in lymph nodes.\n* Patients will be identified as possible participants in the Radiology Imaging suites and Breast Surgery Clinics.\n\nExclusion Criteria:\n\n-Patients with inflammatory breast cancer or distant metastases will be excluded from participating in this study",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}